Related Experiment Video
Updated: Aug 5, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Management of Heyde syndrome with argon plasma coagulation and transcatheter aortic valve implantation
Martin Gomez1, Alejandro Concha2,3, Andres Ruano2
1Director of Gastroenterology Unit, Internal Medicine Department, Universidad Nacional de Colombia, Bogotá, Colombia magomezz@unal.edu.co.
Heyde syndrome (HS) is defined as the association between severe aortic valve stenosis and angiodysplasias (AD)-related bleeding. It is thought to occur as a consequence of an acquired type 2A von Willebrand disease, promoted by the high shear stress generated by the stenotic valve. It appears to be an underdiagnosed condition. We report a case of HS in which gastrointestinal (GI) bleeding was identified in duodenal and jejunal AD. Bleeding was successfully treated with argon plasma coagulation. Additionally, the patient underwent a transcatheter aortic valve implantation, after which he experienced improvement in heart failure symptoms and no further episodes of GI bleeding.
Heyde syndrome (HS) is defined as the association between severe aortic valve stenosis and angiodysplasias (AD)-related bleeding. It is thought to occur as a consequence of an acquired type 2A von Willebrand disease, promoted by the high shear stress generated by the stenotic valve. It appears to be an underdiagnosed condition. We report a case of HS in which gastrointestinal (GI) bleeding was identified in duodenal and jejunal AD. Bleeding was successfully treated with argon plasma coagulation. Additionally, the patient underwent a transcatheter aortic valve implantation, after which he experienced improvement in heart failure symptoms and no further episodes of GI bleeding.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management
Rheumatic Heart Disease III: Medical Management
